
MDxHealth fell 96.5% from $4.45 to $0.16, behind the S&P 500's +9.8%. Its worst day was Oct 16 (−65.8%), and its low came Nov 5 at $0.15.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.16 missed the $-0.12 estimate on $27.4M revenue (est. $25.6M); FY revenue guidance of $108.0M–$110.0M against the $99.8M consensus.
−3.6% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
EPS of $-0.17 missed the $-0.13 estimate on $29.5M revenue (est. $26.0M); FY revenue guidance of $137.0M–$140.0M against the $115.1M consensus.
−4.2% · S&P 500 −0.5%
EPS of $-0.17 missed the $-0.15 estimate on $27.4M revenue (est. $27.2M); FY revenue guidance of $110.0M–$115.0M against the $122.6M consensus.
−49.5% · S&P 500 +0.8%
MDxHealth shares rose 23.5%, while the S&P 500 fell 0.1%.
+23.5% · S&P 500 −0.1%
EPS of $-0.18 beat the $-0.18 estimate on $27.2M revenue (est. $23.2M); FY revenue guidance of $110.0M–$115.0M against the $98.8M consensus.
+74.9%, the year's best day, on 327M shares, the year's heaviest volume · S&P 500 −0.2%
MDxHealth shares fell 65.8%, while the S&P 500 fell 1.1%.
−65.8%, the year's worst day · S&P 500 −1.1%
Where it ended: a close of $0.16 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.09, revenue est. $25.8M).
Nothing in the past 12 months.
All MDXH dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MDXH and SPY from Benzinga historical bars. Not investment advice.